Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
Primary Care and OTC products
With a long history of and a strong proven track record in Primary Care, Takeda Belgium keeps striving towards better health and a brighter future based on a broad portfolio of highly qualitative established medicines that improve the life of more than 2.7 million patients in Belgium and Luxemburg every month (source: IMS data October 2017).
Our Primary Care portfolio counts 35 brands in several therapeutic areas, including diabetes, gastroenterology, food supplements, osteoporosis, thyroid, urology, …
These brands include drugs (prescription or Over the Counter – OTC) as well as food supplements.
Over the decades, we have created leading brands in acid-related diseases, osteoporosis, cardio-vascular, thyroid and other disease areas. Many of those have their own web sites. Hereunder you will find the links to some of those sites:
Social media pages:
Takeda Belgium's Primary Care division remains focused on patients, general practitioners, specialists and pharmacists, with an agile way of engaging, based on personal preferences. Takeda Belgium aims at offering not only products but also services and solutions for patients and health care professionals.
Our cross channel model allows us to interact, both by face to face and digital communication, 24/24 H and 7/7.
Takeda is a patient focused, innovation driven global pharmaceutical company that builds on a distinguished 235 year history, aspiring to bring better health and a brighter future for people worldwide.
The network of Takeda spans over 70 countries and regions worldwide. The Belgian office is located in Zaventem, close to Brussels airport. Day after day, our motivated and driven employees shape the local offer of products and solutions for the better health and brighter future of patients in Belgium and Luxembourg.
At Takeda Belgium, we share the passion and commitment that makes our company worldwide the patient centric, innovation driven pharmaceutical expert it is. Better health and a brighter future are at the heart of what we do. Today, we offer patients and healthcare professionals remarkable breakthroughs in therapeutic areas that call for the strength of an innovative and agile expert.
Takeda Belgium offers patients a wide portfolio of products prescribed by specialists, general practitioners and pharmacists. Our aim is to provide both patients and healthcare professionals the treatments they need, often in therapeutic areas that can be as challenging as oncology, bowel diseases and hematology.
Takeda Belgium's roots go back to 1835, with the creation of Christaens NV, which became Nycomed after a merger, with Sanders Probel. In 2007, Nycomed accquiered Altana Pharma, a large German pharmaceutical company, and gained considerable strength on the Belgian market. In 2011, the company became part of the Takeda group and was renamed Takeda Belgium.